Literature DB >> 20665388

Review: role of genetics in susceptibility and outcome of sarcoidosis.

Johan Grunewald1.   

Abstract

Sarcoidosis develops in genetically predisposed individuals that are exposed to unknown antigens. There is a statistically significant increased risk for the disease among family members of sarcoidosis patients, and the disease differs in different ethnic groups. It is a genetically complex disease, with many genes contributing, both as risk factors but also with an influence on the disease course. The strongest genetic associations with sarcoidosis are found within the major histocompatibility complex (MHC) [human leukocyte antigen (HLA) in humans]-region on chromosome six. This region includes, besides the HLA-class I and class-II genes, a large number of genes important for the immune response and inflammation. The well studied associations between sarcoidosis and HLA-class II molecules indicate specific antigen presentation for T helper cells, which is in agreement with the characteristic finding of lung-accumulated CD4+ T helper cells expressing a limited set of T cell receptors. Strong associations between distinct HLA-DRB1 alleles and the disease phenotype and course have been described, especially so in patient subgroups. Although a large number of genes are associated with sarcoidosis, this review focuses on gene associations and their influence on the disease phenotype, including the disease course. Copyright Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665388     DOI: 10.1055/s-0030-1262206

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  21 in total

Review 1.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

2.  Differential expression of microRNA and predicted targets in pulmonary sarcoidosis.

Authors:  Elliott D Crouser; Mark W Julian; Melissa Crawford; Guohong Shao; Lianbo Yu; Stephen R Planck; James T Rosenbaum; S Patrick Nana-Sinkam
Journal:  Biochem Biophys Res Commun       Date:  2011-12-24       Impact factor: 3.575

Review 3.  Neuro-ophthalmic sarcoidosis.

Authors:  Robert P Baughman; Kenneth L Weiss; Karl C Golnik
Journal:  Eye Brain       Date:  2012-03-13

4.  DRB1*12:01 presents a unique subset of epitopes by preferring aromatics in pocket 9.

Authors:  I-Ting Chow; Eddie A James; Venus Tan; Antonis K Moustakas; George K Papadopoulos; William W Kwok
Journal:  Mol Immunol       Date:  2011-12-23       Impact factor: 4.407

5.  Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans.

Authors:  A M Levin; M C Iannuzzi; C G Montgomery; S Trudeau; I Datta; P McKeigue; A Fischer; A Nebel; B A Rybicki
Journal:  Genes Immun       Date:  2012-11-15       Impact factor: 2.676

Review 6.  Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.

Authors:  Joseph P Lynch; Jennifer Hwang; Jason Bradfield; Michael Fishbein; Kalyanam Shivkumar; Roderick Tung
Journal:  Semin Respir Crit Care Med       Date:  2014-07-09       Impact factor: 3.119

Review 7.  An update on granulomatous diseases of the oral tissues.

Authors:  Faizan Alawi
Journal:  Dent Clin North Am       Date:  2013-08-15

8.  The frequency of diastolic dysfunction in patients with sarcoidosis and it's relationship with HLA DRB1* alleles.

Authors:  Ezgi Ozyilmaz; Rabia Akilli; İlayda Berk; Ali Deniz; Ozlem Goruroglu Ozturk; Oya Baydar; Yasemin Saygideger; Gulsah Seydaoglu; Eren Erken
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

Review 9.  Etiology of sarcoidosis: does infection play a role?

Authors:  Shiv Saidha; Elias S Sotirchos; Christopher Eckstein
Journal:  Yale J Biol Med       Date:  2012-03-29

Review 10.  Genetic testing in diffuse parenchymal lung disease.

Authors:  Paolo Spagnolo; Fabrizio Luppi; Stefania Cerri; Luca Richeldi
Journal:  Orphanet J Rare Dis       Date:  2012-10-17       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.